Description: PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as \
Home Page: pharmacyte.com
3960 Howard Hughes Parkway
Las Vegas,
NV
89169
United States
Phone:
917 595 2850
Officers
| Name | Title |
|---|---|
| Mr. Carlos A. Trujillo CPA, CPA | Chief Financial Officer |
| Mr. Joshua N. Silverman | Interim CEO, Interim Pres & Interim Chairman |
| Dr. Jose L. Iglesias M.D. | Consulting Chief Medical Officer |
| Dr. Hans-Peter Hammes | Member of Medical & Scientific Advisory Board and Consultant |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 9.6452 |
| Price-to-Book MRQ: | 0.6539 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2010-09-17 |
| Fiscal Year End: | April |
| Full Time Employees: | 4 |